NYSE · MPT

Medical Properties Trust, Inc.

$4.79 -$0.05 (-1.03%) 1D After hours

Key Metrics

$2.89B
Market cap
P/E · TTM
$1.00B
Revenue · TTM
−$125.95M
Net income
EPS · TTM $-0.21
Dividend yield
Free cash flow
Beta · 1Y 0.34
EBITDA · TTM $152.28M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    From its Feb 19 high, the share price fell 28%.

    Peak close $6.02 on Feb 19; trough close $4.35 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Mar 11
    The stock moved -8.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 11
  • Feb 19
    The stock moved +12.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 19

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.89B
Enterprise value$12.13B
Shares outstanding598.1M
52-wk range$4.29 – $6.47
Avg volume · 20D6.1M
Net cash −$9.24B
Book value / share$7.57
IndustryReal Estate Investment Trusts
ExchangeNYSE
About Medical Properties Trust, Inc.
IPO dateJul 8, 2005
Employees121

Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.89
P/FCF
EV/EBITDA79.67
EV/Sales12.13
Graham №

Profitability

Gross
Operating -12.8%
Net -12.6%
FCF
ROE / ROIC -2.7% · -0.9%

Financial Health

Current ratio
Quick ratio
Debt / equity2.13
Debt / EBITDA 63.45
Net cash −$9.24B
Working capital

Cash Flow · TTM

Operating CF $216.12M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

-0.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings